Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00004583-199801000-00011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Consumption of psychotropic medications in primary healthcare in Ribeirão Preto, São Paulo State, Brazil].
Cad Saude Publica
April 2021
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brasil.
The consumption of psychotropic drugs is considered a public health problem, due to the potential for addiction and the occurrence of adverse events. In this context, the current study aimed to characterize the consumption of psychotropic medications dispensed in primary healthcare units in Ribeirão Preto, São Paulo State, Brazil. This ecological study consulted the Hygia database from 2008 to 2012.
View Article and Find Full Text PDFRisperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
Psychiatry Res
July 2017
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (INI), Bangalore-560029, Karnataka, India. Electronic address:
There is a dearth of prospective trials studying treatment response in Persistent Delusional Disorder (PDD) to guide clinical practice. Available retrospective data indicate good response to second-generation antipsychotics (SGAs). We selected the data of patients prescribed either olanzapine or risperidone from a retrospective chart review of PDD (n=455) at our centre.
View Article and Find Full Text PDFPrescription trends in children with pervasive developmental disorders: a claims data-based study in Japan.
World J Pediatr
November 2016
Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, 980-8575, Japan.
Background: The only drug approved for pervasive developmental disorders (PDD) in Japan is pimozide. Several psychotropic drugs are also prescribed for offlabel use in Japan, but details regarding their prescription and use are largely unknown. The purpose of this study was to clarify the use of drug treatment in Japanese children with PDD.
View Article and Find Full Text PDFAntipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison.
Clin Psychopharmacol Neurosci
December 2015
Department of Psychiatry, Severance Hospital, Seoul, Korea.
Objective: Early treatment choice is critical in first-episode schizophrenia-spectrum disorders. The purpose of this study was to describe prescribing trends of antipsychotics use in patients with first-episode schizophrenia in 2005 and 2010, respectively.
Methods: We reviewed the medical records of newly treated patients with schizophrenia from a university psychiatric hospital in 2005 (n=47) and 2010 (n=52).
Cognitive impairment and dementia in Parkinson's disease: practical issues and management.
Mov Disord
April 2014
Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey.
Cognitive impairment and dementia pose particular challenges in the management of patients with Parkinson's disease (PD). Decision-making capacity can render patients vulnerable in a way that requires careful ethical considerations by clinicians with respect to medical decision making, research participation, and public safety. Clinicians should discuss how future decisions will be made as early in the disease course as possible.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!